2023-05-16 16:25:19 ET
- Aspira Women's Health ( NASDAQ: AWH ) appoints Torsten Hombeck as Chief Financial Officer, effective June 15, 2023, replacing interim CFO Marlene McLennan.
- Hombeck brings extensive experience from his previous roles, including CFO of Akari Therapeutics ( AKTX ).
- He successfully raised over $44 million during his three-year tenure at Akari Therapeutics.
- Hombeck held key positions at Promethera Biosciences and Cytonet, contributing to the latter's acquisition by Promethera.
- He also served as CFO at Agennix and GPC Biotech .
For further details see:
Aspira Women's Health names Torsten Hombeck as new Chief Financial Officer